Cognitive and neurobehavioral patterns in a sample of Egyptian patients genetically diagnosed with Duchenne muscular dystrophy
Tóm tắt
Children with Duchenne muscular dystrophy report a higher rate of cognitive and psychiatric disorders relative to general population. This study will describe and compare the psychiatric and cognitive problems in DMD patients with healthy controls. A statistically significant difference was found between the case and control groups regarding Total IQ (TIQ) with a mean of (82 ± 16) in cases compared to (94 ± 10) in controls, in which 58% of DMD boys had <90 TIQ and 40% less than 70. We also found that 58% of cases have delayed onset of speech, 38% have attention-deficit/hyperactivity disorder, 6% have autism spectrum disorder, 14% have anxiety disorders, and 22% have major depressive disorder. Ninety-two percent of cases had deletion mutations. According to our results, we conclude that boys with DMD had a lower Total IQ and higher rate of psychiatric disorders than the general population. Also, school attendance and speech development are more affected in DMD patients compared to controls, with more speech delay and dropping out of school. So, the authors of this study recommend establishing cognitive and psychiatric screening as a routine in the evaluation and follow-up of DMD children.
Tài liệu tham khảo
Okubo M, Minami N, Goto K, Goto Y, Noguchi S, Mitsuhashi S, Nishino I (2016) Genetic diagnosis of Duchenne / Becker muscular dystrophy using next-generation sequencing : validation analysis of DMD mutations. J Hum Genet 61:483–489. https://doi.org/10.1038/jhg.2016
Doorenweerd N (2020) Combining genetics, neuropsychology and neuroimaging to improve understanding of brain involvement in Duchenne muscular dystrophy - a narrative review. Neuromuscul Disord 30:437–442. https://doi.org/10.1016/j.nmd.2020.05.001
Orsini M, Carolina A, de Ferreira AF, de Assis ACD, Magalhães T, Teixeira S, Bastos VH, Marinho V, Oliveira T, Fiorelli R, Oliveira AB, de Freitas MRG (2018) Cognitive impairment in neuromuscular diseases: a systematic review. Neurol Int 10:7473. https://doi.org/10.4081/ni.2018.7473
Preethish-Kumar V, Shah A, Polavarapu K, Kumar M, Safai A, Vengalil S, Nashi S, Deepha S, Govindaraj P, Afsar M, Rajeswaran J, Nalini A, Saini J, Ingalhalikar M (2022) Disrupted structural connectome and neurocognitive functions in Duchenne muscular dystrophy: classifying and subtyping based on Dp140 dystrophin isoform. J Neurol 269:2113–2125. https://doi.org/10.1007/s00415-021-10789-y
Rae MG, O’Malley D (2016) Cognitive dysfunction in Duchenne muscular dystrophy: a possible role for neuromodulatory immune molecules. J Neurophysiol 116:1304–1315. https://doi.org/10.1152/jn.00248.2016
Connolly AM, Florence JM, Cradock MM, Malkus EC, Schierbecker JR, Siener CA, Wulf CO, Anand P, Golumbek PT, Zaidman CM, Philip Miller J, Lowes LP, Alfano LN, Viollet-Callendret L, Flanigan KM, Mendell JR, McDonald CM, Goude E, Johnson L, Nicorici A, Karachunski PI, Day JW, Dalton JC, Farber JM, Buser KK, Darras BT, Kang PB, Riley SO, Shriber E, Parad R, Bushby K, Eagle M (2013) Motor and cognitive assessment of infants and young boys with Duchenne muscular dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network. Neuromuscul Disord 23:529–539. https://doi.org/10.1016/j.nmd.2013.04.005
Banihani R, Smile S, Peds DM, Yoon G, Dupuis A, Mosleh M, Snider A, Mcadam L (2015) Cognitive and neurobehavioral profile in boys with Duchenne muscular dystrophy. J Child Neurol 30:1472–1482. https://doi.org/10.1177/0883073815570154
Snow WM, Anderson JE, Jakobson LS (2013) Neuroscience and biobehavioral reviews neuropsychological and neurobehavioral functioning in Duchenne muscular dystrophy: A review. Neurosci Biobehav Rev 37:743–752. https://doi.org/10.1016/j.neubiorev.2013.03.016
Hinton V, Fee R, Goldstein E, De Vivo D (2007) Verbal and memory skills in males with Duchenne muscular dystrophy. Dev Med Child Neurol 49:123–128. https://doi.org/10.1111/j.1469-8749.2007.00123
Poysky J (2007) Behavior patterns in Duchenne muscular dystrophy: report on the Parent Project Muscular Dystrophy behavior workshop 8-9 of December 2006, Philadelphia, USA. Neuromuscul Disord 17:986–994
Cotton SM, Voudouris NJ, Greenwood KM (2005) Association between intellectual functioning and age in children and young adults with Duchenne muscular dystrophy: further results from a meta-analysis. Dev Med Child Neurol 47:257–265. https://doi.org/10.1111/j.1469-8749.2005.tb01131
Gocheva V, Schmidt S, Orsini A-L, Hafner P, Schaedelin S, Weber P, Fischer D (2019) Psychosocial adjustment and parental stress in Duchenne muscular dystrophy. Eur J Paediatr Neurol 23:832–841. https://doi.org/10.1016/j.ejpn.2019.09.008
Taylor PJ, Betts GA, Maroulis S, Gilissen C, Pedersen RL, Mowat DR, Johnston HM, Buckley MF (2010) Dystrophin gene mutation location and the risk of cognitive impairment in Duchenne muscular dystrophy. PLoS One 5:e8803
Wechsler D (2003) Wechsler Intelligence Scale for Children-Fourth Edition: Technical and interpretative manual. The Psychological Corporation, San Antonio
Benton AL (1974) Visual retention test. Psychological Corporation New York, NY
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Hergueta T, Baker R, Dunbar GC (1998) The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59:22–33
Ghanem MH, Ibrahim M, El Behairy AA, El Merghany H (1999) Mini International Neuropsychiatric Interview for children/adolescents (MINI Kid); Arabic version. Egypt Dep Neuropsychiatry, Ain Shams University, Cairo
Conners CK (1999) Conners Rating Scales-Revised. Conners, C K (1999) Conners Rat Scales-Revised. In: Maruish ME (ed) use Psychol Test Treat Plan outcomes Assess. Lawrence Erlbaum Assoc Publishers, pp 467–495
El Sheikh MM, Sadek A, Omar AN, El Nahass G (2003) Psychiatric morbidity in first degree relatives of a sample of ADHD children. MD Thesis. Fac Med Ain Shams University
Carey MP, Faulstich ME, Gresham FM, Ruggiero L, Enyart P (1987) Children’s Depression Inventory: construct and discriminant validity across clinical and nonreferred (control) populations. J Consult Clin Psychol 55:755
Ghareeb GA, Beshai JA (1989) Arabic version of the Children’s Depression Inventory: Reliability and validity. J Clin Child Psychol 18:323–326
Schopler E, Reichler RJ, Renner BR (2010) The childhood autism rating scale (CARS). WPS, Los Angeles
Alqahtani M (2017) كارز-2مقيـاس تقييم التوحد للطفولة --ST Arabic adaptations of The Childhood Autism Rating Scale (CARS-2-ST)
Mayzner MS Jr, Sersen E, Tresselt ME (1955) The Taylor Manifest Anxiety Scale and Intelligence. J Consult Psychol 19:401–403
Abdel-Khalek A (1989) The development and validation of an Arabic form of the STAI: Egyptian results. Pers Individ Differ 10:277–285. https://doi.org/10.1016/0191-8869(89)90100-1
Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WK, Cicchetti D, Leckman JF (1997) Children’s Yale-Brown obsessive compulsive scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844–852
Okasha A, Ragheb K, Attia AH, Seif el Dawla A, Okasha T, Ismail R (2001) Prevalence of obsessive compulsive symptoms (OCS) in a sample of Egyptian adolescents. Encephale 27:8–14
Abbs S, Tuffery-Giraud S, Bakker E, Ferlini A, Sejersen T, Mueller CR (2010) Best Practice Guidelines on molecular diagnostics in Duchenne/Becker muscular dystrophies. Neuromuscul Disord 20:422–427. https://doi.org/10.1016/j.nmd.2010.04.005
Magliano L, D'Angelo MG, Vita G, Pane M, D'Amico A, Balottin U, Angelini C, Battini R, Politano L, Patalano M, Sagliocchi A, Civati F, Brighina E, Vita GL, Messina S, Sframeli M, Lombardo ME, Scalise R, Colia G, Catteruccia M et al (2014) Psychological and practical difficulties among parents and healthy siblings of children with Duchenne vs. Becker muscular dystrophy: an Italian comparative study. Acta Myol 33(3):136–143
Pascual-Morena C, Cavero-Redondo I, Reina-Gutiérrez S, Saz-Lara A, López-Gil JF, Martínez-Vizcaíno V (2022) Prevalence of neuropsychiatric disorders in Duchenne and Becker muscular dystrophies: a systematic review and meta-analysis. Arch Phys Med Rehabil. https://doi.org/10.1016/j.apmr.2022.05.015
López-Hernández LB, Gómez-Díaz B, Escobar-Cedillo RE, Gama-Moreno O, Camacho-Molina A, Soto-Valdés DM, Anaya-Segura MA, Luna-Padrón E, Zúñiga-Guzmán C, Lopez-Hernández JA, Vázquez-Cárdenas NA, Sánchez-Chapul L, Rangel-Villalobos H, Canto P, López-Cardona MG, García S, Méndez-Covarrubias G, Coral-Vázquez RM (2014) Duchenne muscular dystrophy in a developing country: challenges in management and genetic counseling. Genet Couns 25:129–141
Thangarajh M, Hendriksen J, McDermott MP, Martens W, Hart KA, Griggs RC, TREAT-NMD MSG (2019) Relationships between DMD mutations and neurodevelopment in dystrophinopathy. Neurology 93:e1597–e1604. https://doi.org/10.1212/WNL.0000000000008363
Darmahkasih AJ, Rybalsky I, Tian C, Shellenbarger KC, Horn PS, Lambert JT, Wong BL (2020) Neurodevelopmental, behavioral, and emotional symptoms common in Duchenne muscular dystrophy. Muscle Nerve 61:466–474. https://doi.org/10.1002/mus.26803
D’Alessandro R, Ragusa N, Vacchetti M, Rolle E, Rossi F, Brusa C, Davico C, Vitiello B, Mongini T, Ricci FS (2021) Assessing cognitive function in neuromuscular diseases: a pilot study in a sample of children and adolescents. J Clin Med 10:4777
Mahadevappa M, Sekar D, Purushottam M, Thomas PT, Nalini A, Work PS (2020) Duchenne muscular dystrophy and Becker muscular dystrophy confirmed by multiplex ligation-dependent probe amplification: genotype-phenotype correlation in a large cohort. Duchenne Muscular Dystrophy 13:71
Kumar SH, Athimoolam K, Suraj M, Das Christu Das MS, Muralidharan A, Jeyam D, Ashokan J, Karthikeyan P, Krishna R, Khanna-Gupta A, Bremadesam Raman L (2020) Comprehensive genetic analysis of 961 unrelated Duchenne muscular dystrophy patients: focus on diagnosis, prevention and therapeutic possibilities. PLoS One 15:e0232654. https://doi.org/10.1371/journal.pone.0232654
Bladen CL, Salgado D, Monges S, Foncuberta ME, Kekou K, Kosma K, Dawkins H, Lamont L, Roy AJ, Chamova T, Guergueltcheva V, Chan S, Korngut L, Campbell C, Dai Y, Wang J, Barišić N, Brabec P, Lahdetie J, Walter MC, Schreiber-Katz O, Karcagi V, Garami M, Viswanathan V, Bayat F, Buccella F, Kimura E, Koeks Z, van den Bergen JC, Rodrigues M, Roxburgh R, Lusakowska A, Kostera-Pruszczyk A, Zimowski J, Santos R, Neagu E, Artemieva S, Rasic VM, Vojinovic D, Posada M, Bloetzer C, Jeannet P-Y, Joncourt F, Díaz-Manera J, Gallardo E, Karaduman AA, Topaloğlu H, El Sherif R, Stringer A, Shatillo AV, Martin AS, Peay HL, Bellgard MI, Kirschner J, Flanigan KM, Straub V, Bushby K, Verschuuren J, Aartsma-Rus A, Béroud C, Lochmüller H (2015) The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations. Hum Mutat 36:395–402. https://doi.org/10.1002/humu.22758